Scientists said in a study published on Friday in Bangkok that a drug-resistant strain of malaria has spread through South-East Asia and was on the verge of reaching India.

Following the suspension of strike by the Kwara branch of health workers under the umbrella of Coalition of Health Sector Unions (COHESU) on February 3, patients are now patronising public owned hospitals in the state for medical treatment.

Tiny nano-particles that act like miniature drones could deliver a knock-out punch to plaque buildup in the arteries, according to an experimental approach described by US scientists on Wednesday.

Obesity is defined as abnormal or excessive fat accumulation that presents a risk to health. It associated with non-communicable diseases (NCDS) like type 2 diabetes, hypertension, and heart disease. At an individual level, obesity is as a result of the combination of excessive food energy intake and a lack of physical activity. Other causes include inactivity, pregnancy, and lack of sleep, genetics, medical reasons, or psychiatric illness. According to research carried out on Nigeria in the past, over a quarter of Nigeria’s population is obese.

Indian registered pharmaceutical company in Nigeria, Ranbaxy Laboratories, has promised to kick out malaria in Nigeria with its first ever New Chemical Entity (NCE), which according to the CEO and Managing Director of the company, Mr. Arun Sawhney, would address the existing challenges of resistance to available drugs, price fluctuations, supply constraints and high pill burden“.